AU2001267177A1 - Diagnosis and treatment of herpes infections - Google Patents
Diagnosis and treatment of herpes infectionsInfo
- Publication number
- AU2001267177A1 AU2001267177A1 AU2001267177A AU6717701A AU2001267177A1 AU 2001267177 A1 AU2001267177 A1 AU 2001267177A1 AU 2001267177 A AU2001267177 A AU 2001267177A AU 6717701 A AU6717701 A AU 6717701A AU 2001267177 A1 AU2001267177 A1 AU 2001267177A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- treatment
- herpes infections
- herpes
- infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20733700P | 2000-05-30 | 2000-05-30 | |
US60/207,337 | 2000-05-30 | ||
PCT/CA2001/000779 WO2001091786A2 (en) | 2000-05-30 | 2001-05-30 | Diagnosis and treatment of herpes infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001267177A1 true AU2001267177A1 (en) | 2001-12-11 |
Family
ID=22770105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001267177A Abandoned AU2001267177A1 (en) | 2000-05-30 | 2001-05-30 | Diagnosis and treatment of herpes infections |
Country Status (4)
Country | Link |
---|---|
US (1) | US20010049113A1 (en) |
AU (1) | AU2001267177A1 (en) |
CA (1) | CA2410252A1 (en) |
WO (1) | WO2001091786A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10138912A1 (en) * | 2001-08-08 | 2003-02-27 | Medinnova Ges Med Innovationen | Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances |
US20100221228A1 (en) * | 2006-01-24 | 2010-09-02 | The University Of Chicago | y134.5 Deficient HSV and the MAPK Pathway |
WO2010134939A2 (en) * | 2008-12-19 | 2010-11-25 | Zirus, Inc. | Mammalian genes involved in infection |
WO2014022185A2 (en) * | 2012-08-03 | 2014-02-06 | Albert Einstein College Of Medicine Of Yeshiva University | Method to treat or prevent herpesvirus infections |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9608180D0 (en) * | 1996-04-19 | 1996-06-26 | Cancer Res Campaign Tech | Phosphate analogues |
-
2001
- 2001-05-30 US US09/681,740 patent/US20010049113A1/en not_active Abandoned
- 2001-05-30 CA CA002410252A patent/CA2410252A1/en not_active Abandoned
- 2001-05-30 WO PCT/CA2001/000779 patent/WO2001091786A2/en active Application Filing
- 2001-05-30 AU AU2001267177A patent/AU2001267177A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001091786A2 (en) | 2001-12-06 |
US20010049113A1 (en) | 2001-12-06 |
WO2001091786A3 (en) | 2002-08-08 |
CA2410252A1 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000260550A1 (en) | Treatment of skin damage using polyenylphosphatidylcholine | |
AU2001275177A1 (en) | Cardiac disease treatment and device | |
AU2001253565A1 (en) | Cardiac disease treatment and device | |
AU2001275176A1 (en) | Cardiac disease treatment and device | |
AU2001281369A1 (en) | Cardiac disease treatment and device | |
AU5788300A (en) | Medical treatment method and kit | |
AU2002225219A1 (en) | Diagnosis and treatment of multiple sclerosis | |
AU2001283285A1 (en) | Antimicrobial composition and methods of use in the treatment of disease | |
AU2000255628A1 (en) | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections | |
AU2001260834A1 (en) | The treatment of herpes | |
AUPQ622600A0 (en) | Treatment and/or prevention of ocular pain | |
AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
AU2002239485A1 (en) | Methods for improved diagnosis and treatment of mycobacterial infections | |
AU2002220257A1 (en) | Methods of treatment involving human mda-7 | |
AU2281601A (en) | Treatment of viral infections using levovirinTM | |
AU2001259507A1 (en) | Compounds and methods for the diagnosis and treatment of ehrlichia infection | |
AU2001267177A1 (en) | Diagnosis and treatment of herpes infections | |
PL349910A1 (en) | Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections | |
AU3760900A (en) | Treatment of menstrual function | |
AU2001296477A1 (en) | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2002323443A1 (en) | Compositions and methods for the diagnosis and treatment of herpes simplex virus infection | |
AU2002249891A1 (en) | Compounds and methods for the diagnosis and treatment of babesia infection | |
AU2002241162A1 (en) | Intimins in the prevention or treatment of infections:ii | |
AU1392601A (en) | Prevention and treatment of biomaterial-associated infections |